Company intelligence / Profile preview

Zhejiang Yongning Pharmaceutical

Taizhou City / Huangyan District, Zhejiang Province, China

Ownership: Private
Employees: ~1200
Development stage: Other

Overview

Zhejiang Yongning Pharmaceutical is a leading Chinese pharmaceutical manufacturer specializing in semi-synthetic antibiotics, especially cephalosporins, as well as APIs and finished dosage forms. The company has over 100 drug varieties across five categories, with more than 30 APIs and over 80 formulations. Several products have achieved regulatory approvals in China, Japan, and the US. Notable clinical results include approval of Hewei Zhixie Capsule for gastroenteritis and Carthamin yellow for angina pectoris[5][8].

Therapeutic areas: GastroenterologyCardiovascularInfectious Diseases
Modalities: Small moleculeHerbal medicine
Industry: Biotech

Beyond the preview

Go deeper on Zhejiang Yongning Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Yongning Pharmaceutical.

Explore the full profile